‘Much-needed continuity’: Claire Anderson re-elected as RPS president

Professor Claire Anderson has been re-elected as president of the Royal Pharmaceutical Society (RPS), seeing off opposition from former RPS England (RPSE) chair Thorrun Govind.

breaking
Professor Claire Anderson
Professor Claire Anderson told C+D that it has been “an honour” to serve as RPS president.

The RPS today (July 11) announced that its assembly has re-elected Professor Anderson as president for a further two-year term.

In an address to the assembly, she said that she had decided to stand for a second term “to offer much-needed continuity” in a “time of unprecedented change”.

“I am passionate about our profession and committed to making the RPS and our members even more successful”, she said, adding that she “will also continue to be a dedicated ambassador and advocate for the profession nationally and internationally”.

Read more: UPDATED: Erutase Oputu replaces Thorrun Govind as RPS England chair

She told C+D that it has been “an honour” to serve as RPS president.

Professor Anderson was elected as RPS president in July 2021 - replacing Sandra Gidley who served as president for two years - and had previously held the role of RPSE chair from 2019-2021.

Professor Anderson teaches at the University of Nottingham’s school of pharmacy and is “a global leader in pharmacy practice research” who, among other achievements, developed King’s College’s “first community pharmacy diploma”, according to her RPS profile.

Read more: Geraldine McCaffrey elected new RPS Wales board chair

In a statement released today (July 11), unsuccessful candidate Ms Govind congratulated Professor Anderson and said that despite losing the leadership bid, she would “continue to advocate for this profession” and “champion the voices of the next generation”.

“I have always believed in and championed the positive contribution of diverse voices, something I hope has been apparent during my term as chair”, she said.

Ms Govind added that she was looking forward to working with Professor Anderson and other members of the RPS assembly to “ensure the society is working for our members”.

Read more: RPS elects Claire Anderson as its new president

Meanwhile, the RPS also today announced that Alisdair Jones was confirmed by the assembly as its new treasurer, taking over from Sibby Buckle who stood down from the role last month.

A member of the English Pharmacy Board and assembly, Mr Jones was “elected unopposed”, it said.

He is already part of the finance and investment committee where RPS budgets, pensions, assets, financial priorities and performance, reserves and investment policies are scrutinised and agreed, it added.

Sign in or register for free

James Stent

Read more by James Stent

James Stent joined C+D as a digital reporter in May 2023 from the South African human rights news agency GroundUp, where he was senior reporter and consultant editor.

Latest from News

Retired pharmacist crushed to death in canal boat accident

 
• By 
 • comment0

Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.

NHSE scrapped: ‘Fresh start or just more political chaos?’

 
• By 
 • comment2

C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment3

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

More from Business

breaking news

IN FULL: Boots’ parent company sold in $24bn private equity deal

 
• By 
 • comment

Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.

Jhoots accounts: Shareholder funds tumble while debts soar

 
• By 
 • comment

Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.